Ryan P. Owen, Ph.D.

Affiliations: 
2006 University of California, San Francisco, San Francisco, CA 
Area:
Pharmacology, Molecular Biology
Google:
"Ryan Owen"

Parents

Sign in to add mentor
Kathleen M. Giacomini grad student 2006 UCSF
 (Genetic variation and specificity of membrane transporters.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Shu Y, Brown C, Castro RA, et al. (2008) Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics. Clinical Pharmacology and Therapeutics. 83: 273-80
Shu Y, Sheardown SA, Brown C, et al. (2007) Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. The Journal of Clinical Investigation. 117: 1422-31
Owen RP, Badagnani I, Giacomini KM. (2006) Molecular determinants of specificity for synthetic nucleoside analogs in the concentrative nucleoside transporter, CNT2. The Journal of Biological Chemistry. 281: 26675-82
Owen RP, Lagpacan LL, Taylor TR, et al. (2006) Functional characterization and haplotype analysis of polymorphisms in the human equilibrative nucleoside transporter, ENT2. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 34: 12-5
Owen RP, Gray JH, Taylor TR, et al. (2005) Genetic analysis and functional characterization of polymorphisms in the human concentrative nucleoside transporter, CNT2. Pharmacogenetics and Genomics. 15: 83-90
Gray JH, Mangravite LM, Owen RP, et al. (2004) Functional and genetic diversity in the concentrative nucleoside transporter, CNT1, in human populations. Molecular Pharmacology. 65: 512-9
Gray JH, Owen RP, Giacomini KM. (2004) The concentrative nucleoside transporter family, SLC28. PflüGers Archiv : European Journal of Physiology. 447: 728-34
Gray J, Owen R, Urban T, et al. (2003) Functional characterization of genetic variants of the nucleoside transporter, CNT1 Clinical Pharmacology & Therapeutics. 73: P59-P59
See more...